Polyethylene glycol-modified thymus peptide 1 derivatives
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- JIANGSU HANSOH PHARMA CO LTD
- Publication Date
- 2005-11-02
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the preparation and application of long-acting thymosin 1 derivatives. It specifically relates to polyethylene glycol-modified thymosin 1 derivatives. technical background
[0002] The thymus is an important immune organ in the body and plays an important role in the development of the lymphatic system and maintaining the normal function of the immune system. Especially, it has special significance in anti-infection, anti-tumor, autoimmune diseases and organ transplantation. As the body ages, the thymus gradually shrinks and degenerates, and the incidence of tumors, infections, and immune diseases gradually increases. In recent years, foreign scholars have purified thymosin into several individual components, and found that the biological activity of thymosin 1 is 10-1000 times higher than that of thymosin mixture. Thymosin 1 belongs to the fifth component of thymosin, which has an immunoregulatory effect. It can ind...